Investing

Investor Insight Green Technology Metals aims to build Ontario’s first integrated lithium business, developing two mining hubs and a downstream conversion facility to supply North America’s fast-growing EV and battery industry. The company’s approach is…

US-China tensions are causing a shift in global gold market dynamics. Escalating trade tensions with the US have prompted China to take a defensive stance economically. This has become a major gold price driver in…

Here’s a quick recap of the crypto landscape for Monday (September 15) as of 9:00 p.m. UTC. Get the latest insights on Bitcoin, Ethereum and altcoins, along with a round-up of key cryptocurrency market news.…

Brightstar Resources (BTR:AU) has announced Over 50% Q-o-Q Production Growth Targeted Download the PDF here. This post appeared first on investingnews.com

John Feneck, portfolio manager and consultant at Feneck Consulting, shares his outlook for gold and silver prices in 2025. His next target for gold is US$3,800 per ounce, and he still expects US$50 per ounce…

The gold sector is undergoing another wave of portfolio reshuffling. Fresh deals across the sector signal a growing shift toward consolidation and selective asset sales as stakeholders seek further growth during the yellow metal’s historic…

Alvopetro Energy Ltd. (TSXV: ALV,OTC:ALVOF) (OTCQX: ALVOF) announces that our Board of Directors has declared a quarterly dividend of US$0.10 per common share, payable in cash on October 15, 2025 to shareholders of record at…

Alice Queen (AQX:AU) has announced Alice Queen raises $1M via issue of Convertible Notes Download the PDF here. This post appeared first on investingnews.com

Founded in 2009 and listed in 2011, Angkor Resources (TSXV:ANK,OTCQB:ANKOF) has developed a dual focus on energy and minerals across Asia and North America. Angkor Resources is advancing a dual-track strategy across energy and minerals.…

lobe sciences ltd. (CSE: LOBE,OTC:LOBEF) (OTCQB: LOBEF) (FSE: LOBE.F) (‘Lobe Sciences’ or the ‘Company’) a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce its participation…